Fig. 1From: Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional studyKaplan–Meier survival curve for progression-free survival for group A and group BBack to article page